A Team of Scientists from MIT have developed a method for unveiling the genetic code of heparan sulfate (a sugar molecule found on the surface of all cells in the body) and heparin (a commercial drug used to stop clotting).
A Team of Scientists from MIT have developed a method for unveiling the genetic code of heparan sulfate (a sugar molecule found on the surface of all cells in the body) and heparin (a commercial drug used to stop clotting).
For years, researchers have been able to determine the genetic codes of protein and DNA, however, doing the same for sugars has proven to be troublesome because of the complexity of these molecules.
Led byMIT Professor of Biology Robert D. Rosenberg and postdoctoral associates Kuberan Balagurunathan and Zhengliang L. Wu, technical associate Miroslaw Lech, research affiliate Lijuan Zhang, and research scientist David Beeler, the technique developed by the group uses LC-MS.
To view, please visit: http://web.mit.edu/newsoffice/nr/2002/sugar2.html
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.